Kishore Kumar Poludasu,MD and CEO,SBI General Insurance "The retail...
Category:
Indian News
Latest
US food regulator gathering information on Indian spices after alleged contamination
MDH and Everest spices are among the most popular in India and are...
6th Bima Manthan: Panda and insurance CEOs brainstorm on Bima Trinity, new products and data
Debasish Panda,chairman,IRDAI The industry's preparedness for...
NGT directs CPCB to recover fine from Amazon, Flipkart for excessive plastic packaging
“The CPCB can also consider ordering environmental audit against the concerned entities and assess and recover compensation for violation of environmental norms, following due process of law,” the bench said.
Recoveries surge to 36 24 196 60 per cent of total recoveries concentrated in 5 states
Sixty per cent of the total recovered cases are being reported from five states – Maharashtra, Tamil Nadu, Andhra Pradesh, Karnataka and Uttar Pradesh, the ministry said on Saturday.
AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness
The Serum Institute of India said it would restart its trials once it had permission from the Drugs Controller General of India
Centre lists 23 new Bills for monsoon session of Parliament,LIC Act Amendment not yet: Report
One of the ordinances the government plans to pass as a bill during the 18-day-long session relates to providing preventive measures against violence on healthcare personnel.
Record 96,551 COVID-19 new cases, tally crosses 45-lakh mark
The COVID-19 case fatality rate has further dropped to 1.67 per cent while the recovery rate was recorded at 77.65 per cent.
There are 9,43,480 active cases of COVID-19 in the country which comprises 20.68 per cent of the total caseload, the data stated.
India staring at another health disaster amid a raging battle with Covid-19
But the biggest crisis is India’s longstanding battle with tuberculosis. The country has as many as 2.7 million TB patients currently, by far the most in the world, and the disease kills an estimated 421,000 Indians each year. The current gap in care could lead to an additional 6.3 million cases and 1.4 million deaths from tuberculosis by 2025, according to a study by Zarir Udwadia, a pulmonologist at Mumbai’s P.D. Hinduja Hospital and Medical Research Centre.
Passenger vehicle sales increase 14% in August to 215,916 units: SIAM
According to the latest data by the Society of Indian Automobile Manufacturers (SIAM), two-wheeler sales also rose 3 per cent at 15,59,665 units, as compared to 15,14,196 units in the same month last year.
Motorcycle sales were at 10,32,476 units as against 9,37,486 units in August 2019, up 10.13 per cent.
IRDAI plans broad basing exclusive Carona covers, moots digital health insurance claim platform:Alamelu
“We are thinking of ways and means, sooner than later we will issue instructions on how standardised Covid-specific health insurance policies can be mainstreamed, renewed, features of porting migration so that Corona Rakshak and Corona Kavach policyholders continue to get a good cover not only for Covid but entire health sector.” said T.L. Alamelu,member (Non-Life),IRDAI on Friday while addressing an ASSOCHAM National e-Summit on Challenges, Opportunities & Way Forward for Health Insurance Under Covid Attack.
She also indicated that the regulator is currently is working on plans to develop a digital claim settlement mechanism involving all stakeholders – policyholders, insurers, TPAs, hospitals that could be stitched up with National Digital Health Mission.
Puri launches framework for cities to inculcate climate-sensitive approach to urban planning
At a virtual event, after launching ”Climate Smart Cities Assessment Framework 2.0”, Puri said, “It is estimated that climate change will impact the Indian GDP by 2-6 per cent on an annual basis.
“This means that our future development goals and investments will also be severely affected if we do not address climate risks now.”
DCGI issues notice to Serum Institute over Oxford’s Covid trial suspension
“Whereas, Serum Institute of India Pvt Ltd, Pune, till now has not informed the Central licensing authority regarding pausing the clinical trial carried out by AstraZeneca in other countries and also not submitted casualty analysis of the reported serious adverse event with the investigational vaccine for the continuation of phase 2 and 3 clinical trials of the subject vaccine in the country in light of the safety concerns,” said the show-cause notice accessed by PTI.